Valentina Guarneri

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2021 · 689 citations · Full text

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Sibylle Loibl, Fabrice André, Thomas Bachelot et al. · Annals of Oncology · 2023 · 684 citations · Full text

Surgical Oncology, Breast Oncology, Early Breast Cancer +7

Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates

Ana O. Hoff, Béla B. Toth, Kadri Altundağ et al. · Journal of Bone and Mineral Research · 2008 · 632 citations · Full text

Prognostic Value of Pathologic Complete Response After Primary Chemotherapy in Relation to Hormone Receptor Status and Other Factors

Valentina Guarneri, Kristine Broglio, Shu‐Wan Kau et al. · Journal of Clinical Oncology · 2006 · 596 citations

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

Maria Vittoria Dieci, Carmen Criscitiello, Aïcha Goubar et al. · Annals of Oncology · 2014 · 461 citations · Full text

Residual Disease, Breast Oncology, Medicine +9